Log in  First Connection?

ATTR Amyloidosis: Archives News of the month

Increasing clinicians’ suspicion of ATTR amyloidosis using a retrospective algorithm

 Published on 04/04/2025 |  Original article (Abstract)  | Ammon Jessica et al. | Cardio-Oncology 2024; 10(1): 78

Amyloidosis is a disease characterized by extracellular tissue deposition of insoluble fibrils composed of abnormally folded proteins. Two types of amyloidosis are responsible for 95% of cardiac amyloidosis cases, immunoglobulin light chain amyloidosis (AL) and transthyretin amyloidosis (ATTR). ATTR...

Sudoscan in ATTRv Amyloidosis: A Potential Marker of Disease Progression?

 Published on 28/03/2025 |  Original article (Abstract)  | Angela Romano et al. | Neurology and Therapy 2025; aop: 10.1007/s40120-025-00721-1

Hereditary transthyretin amyloidosis (ATTRv, v for ‘variant’) is a rare, adult-onset, autosomal-dominant disease with variable penetrance, caused by mutations in the TTR gene encoding transthyretin. Pathogenic TTR variants decrease the stability of the TTR tetramer...

Diagnostic performance of liver stiffness as marker of liver involvement in systemic immunoglobulin light chain (AL) amyloidosis

 Published on 21/03/2025 |  Original article (Abstract)  | Brunger Anne F. et al. | Annals of Hematology 2025; 104(1): 653-63

In systemic immunoglobulin light chain (AL) amyloidosis, heart involvement has most impact on survival [1]. However, liver involvement also affects prognosis [2, 3] and increases the risk of treatment-related toxicity [4]. Identification of liver involvement at the start of treatment provides parameters...

Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective study

 Published on 14/03/2025 |  Original article (Abstract)  | Péréon Yann et al. | Orphanet Journal of Rare Diseases 2025; 20(1): 95

Chronic inflammatory demyelinating-like polyradiculoneuropathy (CIDP) is an autoimmune disease of the peripheral nervous system affecting myelin. CIDP is rare, with a reported prevalence ranging from 0.15 to 8.9 cases/100 000 individuals [1, 2–3] and may present at any age. The typical form is...

Rare case of wtTTR amyloidosis and MGUS in a patient with lung adenocarcinoma

 Published on 07/03/2025 |  Original article (Abstract)  | Ahmad Safdar et al. | BMJ case reports 2024; 17(12): e262081

Amyloid fibril deposition has been described in patients with malignancy, more frequently in haematologic neoplasms than solid tumours. Amyloid transthyretin (ATTR) amyloidosis is commonly known for its cardiac or neurological involvement. Pulmonary involvement is relatively uncommon and poorly characterised....